Literature DB >> 9056021

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori.

G G Stone1, D Shortridge, J Versalovic, J Beyer, R K Flamm, D Y Graham, A T Ghoneim, S K Tanaka.   

Abstract

We have developed a rapid PCR-oligonucleotide ligation assay that can discriminate single base substitutions that are associated with clarithromycin resistance in Helicobacter pylori. Susceptible isolates were wild type at positions 2143 and 2144 (cognate to 2058 and 2059 in Escherichia coli), while 93% of the resistant isolates contained A-to-G mutations at either position and 7% of the isolates contained A-to-C mutations at position 2143. In addition, the MIC for 86% of the resistant isolates with an A2143 mutation was > or = 64 micrograms per ml, and that for 89% of the resistant isolates with an A2144 mutation was < or = 32 micrograms per ml.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056021      PMCID: PMC163779     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay.

Authors:  D A Nickerson; R Kaiser; S Lappin; J Stewart; L Hood; U Landegren
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli.

Authors:  C D Sigmund; M Ettayebi; A Borden; E A Morgan
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin.

Authors:  B Vester; R A Garrett
Journal:  Biochimie       Date:  1987-08       Impact factor: 4.079

4.  Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori.

Authors:  G G Stone; D Shortridge; R K Flamm; J Versalovic; J Beyer; K Idler; L Zulawinski; S K Tanaka
Journal:  Helicobacter       Date:  1996-12       Impact factor: 5.753

5.  Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.

Authors:  R C Goldman; D Zakula; R Flamm; J Beyer; J Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

6.  Ordered cosmid library and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638.

Authors:  N O Bukanov; D E Berg
Journal:  Mol Microbiol       Date:  1994-02       Impact factor: 3.501

7.  Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Authors:  T S Lucier; K Heitzman; S K Liu; P C Hu
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

8.  Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.

Authors:  K A Nash; C B Inderlied
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

9.  PCR-based restriction fragment length polymorphism typing of Helicobacter pylori.

Authors:  S Fujimoto; B Marshall; M J Blaser
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

10.  Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA.

Authors:  D Moazed; H F Noller
Journal:  Biochimie       Date:  1987-08       Impact factor: 4.079

View more
  52 in total

1.  Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori.

Authors:  J R Gibson; N A Saunders; B Burke; R J Owen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

Review 2.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.

Authors:  T Alarcón; D Domingo; N Prieto; M López-Brea
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization.

Authors:  H Rüssmann; K Adler; R Haas; B Gebert; S Koletzko; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Clarithromycin resistance in Helicobacter pylori and its clinical relevance.

Authors:  Hua-Xiang Xia; Xue-Gong Fan; Nicholas J Talley
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

Review 6.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects.

Authors:  Paolo Scarpellini; Paola Carrera; Annalisa Cavallero; Massimo Cernuschi; Gianni Mezzi; Pier Alberto Testoni; Anna Zingale; Adriano Lazzarin
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Detection of Helicobacter pylori in paraffin-embedded and in shock-frozen gastric biopsy samples by fluorescent in situ hybridization.

Authors:  Holger Rüssmann; Anne Feydt-Schmidt; Kristin Adler; Daniela Aust; Almuth Fischer; Sibylle Koletzko
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 9.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

10.  T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh.

Authors:  Rasel Khan; Shamsun Nahar; Jinath Sultana; Mian Mashhud Ahmad; Motiur Rahman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.